Signet Healthcare Partners backs Medicure buy into Apicore
Medicure Inc TSXV: MPH) has bought a minority interest in Apicore, a private developer and manufacturer of specialty active pharmaceutical ingredients. The acquisition was made through a US$22.5 million deal involving U.S. private equity firm Signet Healthcare Partners, which provided an equity investment, and Knight Therapeutics Inc and Sanders Morris Harris Inc, which provided debt financing. Under the terms of the deal, Medicure received an option to acquire all of the remaining shares of Apicore within the next three years. Based in Winnipeg, Manitoba, Medicure is a specialty pharmaceutical company focused on developing and commercializing novel small molecule therapeutics.
3 July 2014•7 mins read
